Related references
Note: Only part of the references are listed.Disruption of the CRF2 receptor pathway decreases the somatic expression of opiate withdrawal
Francesco Papaleo et al.
NEUROPSYCHOPHARMACOLOGY (2008)
CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats
Olivier George et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats
Cindy K. Funk et al.
BRAIN RESEARCH (2007)
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine:: A novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism
Donald R. Gehlert et al.
JOURNAL OF NEUROSCIENCE (2007)
Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats
Adrie W. Bruijnzeel et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats
Laura E. O'Dell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats
Cindy K. Funk et al.
JOURNAL OF NEUROSCIENCE (2006)
Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward:: paradoxical positive incentive effects in stress?
Susana Pecina et al.
BMC BIOLOGY (2006)
Severe deficit in brain reward function associated with fentanyl withdrawal in rats
AW Bruijnzeel et al.
BIOLOGICAL PSYCHIATRY (2006)
The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence
AW Bruijnzeel et al.
BRAIN RESEARCH REVIEWS (2005)
Psychostimulant withdrawal as an inducing condition in animal models of depression
AM Barr et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
DH Overstreet et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats
AW Bruijnzeel et al.
NEUROPHARMACOLOGY (2004)
Increased anxiety-like behavior and ethanol self-administration in dependent rats: Reversal via corticotropin-releasing factor-2 receptor activation
GR Valdez et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation
D Debruyne et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Role of the bed nucleus of the stria tenninalis versus the amygdala in fear, stress, and anxiety
DL Walker et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Neuroadaptive effects of active versus passive drug administration in addiction research
EH Jacobs et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
A 'crash' course on psychostimulant withdrawal as a model of depression
AM Barr et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal
F Frenois et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake
MF Olive et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal
GP McNally et al.
NEUROSCIENCE (2002)
Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens
P Rada et al.
PSYCHOPHARMACOLOGY (2001)
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats
AA Harrison et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Drug dependence, a chronic medical illness - Implications for treatment, insurance, and outcomes evaluation
AT McLellan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist
DJ Macey et al.
BRAIN RESEARCH (2000)
Excessive ethanol drinking following a history of dependence: Animal model of allostasis
AJ Roberts et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression:: the first 20 patients treated
AW Zobel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
JM Delfs et al.
NATURE (2000)
Share Paper
